We are live on ! Find out more
SS

SBI Securities Portfolio holdings

AUM $4.4B
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-4.88%
1 Year Est. Return
+74.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3B
AUM Growth
-$249M
Cap. Flow
+$27.1M
Cap. Flow %
0.9%
Top 10 Hldgs %
42.51%
Holding
4,288
New
218
Increased
1,813
Reduced
1,179
Closed
157

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$27.4M
2
PLTR icon
Palantir
PLTR
+$17.8M
3
MSFT icon
Microsoft
MSFT
+$7.99M
4
UBER icon
Uber
UBER
+$6.25M
5
COST icon
Costco
COST
+$4.76M

Sector Composition

Rank Sector Weight
1 Technology 25.36%
2 Consumer Discretionary 6.74%
3 Communication Services 5.66%
4 Financials 4.36%
5 Healthcare 3.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFBC icon
3501
Preferred Bank
PFBC
$1.23B
$84 ﹤0.01%
1
-5
-83% -$433
AMBR
3502
Amber International Holding Ltd
AMBR
$131M
$84 ﹤0.01%
7
ACCD
3503
DELISTED
Accolade Inc
ACCD
$84 ﹤0.01%
12
+3
+33% +$20
FWDI
3504
Forward Industries Inc
FWDI
$302M
$83 ﹤0.01%
20
MCS icon
3505
Marcus Corp
MCS
$752M
$83 ﹤0.01%
5
SPRC icon
3506
SciSparc
SPRC
$2.87M
$83 ﹤0.01%
+2
New +$181
APRE icon
3507
Aprea Therapeutics
APRE
$7.74M
$82 ﹤0.01%
40
MXC icon
3508
Mexco Energy
MXC
$18.4M
$82 ﹤0.01%
10
MXCT icon
3509
MaxCyte
MXCT
$109M
$82 ﹤0.01%
+30
New +$118
AKRO
3510
DELISTED
Akero Therapeutics
AKRO
$81 ﹤0.01%
2
AVAH icon
3511
Aveanna Healthcare
AVAH
$2.11B
$81 ﹤0.01%
+15
New +$71
BGSF icon
3512
BGSF Inc
BGSF
$55.7M
$81 ﹤0.01%
22
CAC icon
3513
Camden National
CAC
$927M
$81 ﹤0.01%
2
JANX icon
3514
Janux Therapeutics
JANX
$950M
$81 ﹤0.01%
3
SYRE icon
3515
Spyre Therapeutics
SYRE
$8.69B
$81 ﹤0.01%
5
BOLT icon
3516
Bolt Biotherapeutics
BOLT
$7.64M
$80 ﹤0.01%
10
CTKB icon
3517
Cytek Biosciences
CTKB
$570M
$80 ﹤0.01%
20
+10
+100% +$52
CZNC icon
3518
Citizens & Northern Corp
CZNC
$441M
$80 ﹤0.01%
4
-1
-20% -$20
NKSH icon
3519
National Bankshares
NKSH
$244M
$80 ﹤0.01%
3
WTBA icon
3520
West Bancorporation
WTBA
$472M
$80 ﹤0.01%
4
+1
+33% +$21
CERO
3521
DELISTED
CERo Therapeutics
CERO
$80 ﹤0.01%
6
+3
+100% +$119
ALXO icon
3522
ALX Oncology
ALXO
$272M
$79 ﹤0.01%
126
+104
+473% +$125
SLN
3523
Silence Therapeutics
SLN
$570M
$79 ﹤0.01%
28
TNET icon
3524
TriNet
TNET
$2.94B
$79 ﹤0.01%
1
VSTS icon
3525
Vestis
VSTS
$2.03B
$79 ﹤0.01%
8

Similar funds

SBI Securities's Q1 2025 Portfolio in Review

As of Q1 2025, SBI Securities held 4,288 positions worth $3B, down 7.7% from $3.25B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

SBI Securities's Q1 2025 filing shows 218 new, 1,813 increased, 1,179 reduced and 157 closed positions. Its largest new stake was Cohen Circle Acquisition Corp. I Class A Ordinary Shares: 269,058 shares worth $3.02M. The largest sale was NVIDIA, an estimated $27.4M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • SBI Securities's largest Q1 2025 buy was Cohen Circle Acquisition Corp. I Class A Ordinary Shares: 269,058 shares worth $3.02M.
  • SBI Securities added most to Berkshire Hathaway Class B in Q1 2025, an estimated $19.8M increase.
  • SBI Securities's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $27.4M.
  • SBI Securities fully exited Mercado Libre in Q1 2025, selling an estimated $3.93M.
  • SBI Securities's ten largest holdings make up 43% of its $3B portfolio in Q1 2025.
  • SBI Securities opened 218 new positions and closed 157 in Q1 2025.
  • SBI Securities's portfolio value fell 7.7% quarter-over-quarter to $3B.

Based on SBI Securities's 13F filing for Q1 2025, filed 2 May 2025.